1. Anterior Gradient 3 Promotes Breast Cancer Development and Chemotherapy Response
   Qiao Xu et al, 2020, Cancer Research and Treatment CrossRef
2. 15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
   Jingjing Li et al, 2019, PPAR Research CrossRef
3. Divergent proliferation patterns of distinct human hair follicle epithelial progenitor niches in situ and their differential responsiveness to prostaglandin D2
   Talveen S. Purba et al, 2017, Scientific Reports CrossRef
4. Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF‑κB signaling pathways
   Jianxin Zhang et al, 2017, Experimental and Therapeutic Medicine CrossRef
5. AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders
   Trevor M. Penning, 2019, Molecular and Cellular Endocrinology CrossRef
6. Synergistic Antiproliferative Effects of Combinedγ-Tocotrienol and PPARγAntagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
   Abhita Malaviya et al, 2014, PPAR Research CrossRef
7. The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
   Iason Psilopatis et al, 2023, International Journal of Molecular Sciences CrossRef
8. Roles of AKR1C3 in malignancy
   Xin-Zhu Xiao et al, 2021, Chinese Medical Journal CrossRef
9. Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation
   Bohae Rachel Lee et al, 2021, Frontiers in Physiology CrossRef
10. Fatty acids and their lipid mediators in the induction of cellular apoptosis in cancer cells
    Pritam Biswas et al, 2022, Prostaglandins & Other Lipid Mediators CrossRef